PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
Thoracic Cancer ( IF 2.3 ) Pub Date : 2022-05-13 , DOI: 10.1111/1759-7714.14466
Jinjie Wang _{1,

2} , Muqi Shi ₃ , Haijian Zhang _{1,

4} , Hao Zhou _{1,

2} , Zhanghao Huang _{1,

2} , Youlang Zhou ₄ , Jiahai Shi _{1,

2,

5}

Affiliation

Lung adenocarcinoma (LUAD) is one of the tumor-related diseases with high morbidity worldwide. Epigenetic modifications such as DNA methylation changes may involve in tumorigenesis. This study aimed to explore new biomarkers that have prognostic significance of LUAD.

中文翻译：